csua.org/u/9dn -> www.hospitalmanagement.net/contractors/critical/draeger/press3.html
DRGER MEDICAL LAUNCHES NEW INFINITY PATIENT MONITORING SOLUTIONS FOR PERIOPERATIVE CARE Saturday, June 05, 2004 4:01:06 PM Lbeck (Germany) / Lisbon (Portugal) June 5, 2004 Drger Medical AG & CO. KGaA, Lbeck, presents its latest solutions for anesthesiology at the E uroanaesthesia 2004, the Annual Meeting of the European Society of Anaes thesiologists (ESA) to be held 5-8 June in Lisbon. Infinity Patient Moni toring System innovations include the Infinity Kappa XLT split-screen p atient monitor, the InfinityTrident SmartPod for neuromuscular monitorin g, the Infinity BISx SmartPod for measuring the effects of sedation, an d the MonoLead ECG cable. These fully integrated products form part of a comprehensive CareArea solution from Drger Medical for the anesthesia workplace. Infinity Kappa XLT monitor provides Clinical Vision In the OR and other high-acuity environments, accurate assessments and fa st decisions depend on having immediate access to all relevant patient i nformation. The Infinity Kappa XLT is the first split-screen, single-us er patient monitor that is designed for space-constrained areas such as the OR, Kappa XLT lets clinicians see expanded monitoring arranged accor ding to clinical context on one section of the screen, while displaying real-time vital signs and continuous trending on the other section. Ther e are no compromising pop-ups or obstructions of any kind on either sect ion. Kappa XLT expands patient monitoring by providing both real-time data and a comprehensive view of the patients changing condition, says Dave Caml in, group product manager for the Infinity System. We call this Clinical Vision an uncompromised picture of all relevant patient information for informed assessment, analysis, and intervention planning. Kappa XLT more than doubles the traditional number of monitoring paramete rs and waveforms that can be viewed simultaneously. The intuitive user i nterface which has the familiar look and feel of other Drger Medical pr oducts such as the Fabius GS and Primus anesthesia machines is optimized for the one-to-one, caregiver-to-patient situations typical of speciali zed care settings. A 17-inch touch screen displays everything the clinician needs to see tre nds and real-time data, up to 32 waveforms, specialized parameters such as neuromuscular transmission for perioperative assessment all at once. The clinician can preset options, or instantly configure the screen for the specific needs of each patient. As the acuity of the patient changes, the monitor automatically re-config ures as the clinician connects or disconnects additional parameters. An optional browser provides access to Web-based applications and access to other information via the hospitals intranet. Kappa XLT also provides seamless connectivity to multiple bedside devices simultaneously displaying parameter and waveform information from venti lators, anesthesia systems, and other point-of-care devices. Trident and BISx pods introduce Infinity anesthesia effect monitoring Drger Medical will also launch the Infinity Trident and the BISx SmartPo ds, which provide an integrated approach to measuring the effects of ane sthesia on a patient. The Infinity Trident pod with neuromuscular transm ission monitoring (NMT) is based on Train-of-Four (TOF) principles. NMT parameters provide an objective indication of the level of muscle relaxa tion in patients under the influence of neuromuscular blocking agents, e nabling the care provider to make an evidence-based judgment about the s tate of the patients neuromuscular blockade. The Infinity BISx pod incor porates BIS extended platform (XP) technology from Aspect Medical Syste ms. The Bispectral Index (BIS) indicates the effects of sedation on the brain, allowing clinicians to deliver anesthesia with more precision an d assess and respond to a patients changing condition while under anesth esia. MonoLead ECG Cable simplifies ECG monitoring Drger Medical will also demonstrate the new MonoLead ECG cable, a patent ed one-wire ECG lead-set solution for Infinity 3-, 5- and 6- lead monito ring in the OR, telemetry and emergency departments. MonoLead is designe d to be tangle-resistant, easy to clean, easy to apply and more comforta ble for the patient. BISx, BIS and Bispectral Index are registered trademarks of Aspect Medica l Systems. The Infinity Kappa XLT monitor, the Infinity Trident pod and the Infinity BISx pod require 510 review and are not yet available commercially i n the US The Infinity Kappa XLT monitor, the Infinity Trident pod and the Infinity BISx pod are not yet licensed in accordance with Canadian Medical Devic e Regulations IVenus and Primea are not available for sale in the US About Drger Medical: Drger Medical is one of the world's leading manufacturers of medical tec hnolgoy for life. As the largest division of Drgerwerk AG (founded in 1 889), Drger Medical AG & Co. KGaA is a 65:35 joint venture company betw een Drgerwerk AG and Siemens AG. The Company offers products, integrate d systems and services throughout the entire patient care process in all CareAreas - Emergency Care, OR/Anesthesia, Critical Care, Perinatal Car e and Home Care. With headquarters in Lbeck, Germany, Drger Medical AG & Co. KGaA employed approximately 5,400 people worldwide throughout 200 3, more than 50 percent of which work in Customer Sales & Services. The Company has sales and service subsidiaries in over 40 countries and is represented in more than 190. In fiscal year 2003 (= calendar year) the Company increased i ts net sales by around 8 percent to reach 917,7 million (up from 848 ,3 million) and posted an EBIT (before the one-time joint venture expens es) of 91,4 million in 2003 (up from 76,6 million). KGaA continues to outpace the market with a growth rate of aroun d 7 percent per year. The Company increased its EBIT from 9,1 million in 2000 to 91,4 million in 2003, marking the first three years of its business turnaround. KGaA provides innovative so lutions which are the result of a close dialog with customers, over a ce ntury of experience in the market, and continuous investment in R&D.
|